Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Vascular Diseases 1Rectal Neoplasms 1Precancerous Conditions 1Neurotoxicity Syndromes 1Myocardial Ischemia 1Myocardial Infarction 1Heart Diseases 1Fibrosis 1Fatigue 1Erectile Dysfunction 1Coronary Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cerebrovascular Disorders 1Cardiovascular Diseases 1Brain Neoplasms 1Adenomatous Polyps 1

Interventions

Taxes 2Paclitaxel 2Oxaliplatin 2Magnesium Sulfate 2Carboplatin 2Calcium Gluconate 2haloperidol decanoate 1glutamic acid diethyl ester 1axicabtagene ciloleucel 1Vitamin E 1Vincristine 1Thalidomide 1Surveys and Questionnaires 1Rituximab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1Procarbazine 1Peripheral Blood Stem Cell Transplantation 1Pain Management 1Modafinil 1Methotrexate 1Memantine 1Melphalan 1Lorazepam 1Leucovorin 1Lamotrigine 1Ketamine 1Interleukin 1 Receptor Antagonist Protein 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neurotoxicity Syndromes × Vitamin E × Clear all
NCT00363129 2016-07-06

Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
207 enrolled 13 charts

Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡